The Wegovy Pill is an oral alternative to the traditional semaglutide injection. It works by mimicking GLP-1 (glucagon-like peptide-1), a natural hormone that plays a key role in managing your appetite. By replicating this hormone's natural effects, the daily tablet suppresses hunger signals, slows down your digestion, and extends the feeling of fullness after meals.
The Wegovy Pill is a prescription-only daily tablet designed to aid long-term medical weight management. It contains the active ingredient semaglutide, which belongs to a class of medications known as GLP-1 receptor agonists. The medication works by mimicking a natural gut hormone called GLP-1 that controls appetite. It interacts with hunger signals in the brain to quiet down persistent "food noise," reduces overall cravings, and slows down gastric emptying (the speed at which food leaves your stomach). This keeps you feeling significantly fuller and satisfied for longer after smaller meals, making it much easier to sustain a necessary calorie deficit.
Wegovy tablets are licensed for adults in the UK who are committed to a structured weight management plan alongside a lower-calorie diet and increased physical activity. To qualify, you must have:
The prescribers will also review your medical history and decide the suitability of the treatment for you. The final decision lies solely with the prescriber. Terms & conditions and eligibility criteria apply.
To allow your digestive system to safely adapt to the medication and minimise potential stomach upsets, the Wegovy Pill uses a progressive step-up (titration) schedule over a 4-month period.
In the landmark OASIS 4 clinical trial, the Wegovy Pill demonstrated exceptional weight-loss outcomes. Over the course of 64 weeks, adults taking the maximum 25mg daily maintenance dose alongside structured lifestyle adjustments lost an average of 16.6% of their starting weight. To put that into perspective, an individual starting at 100kg lost an average of 16.6kg.
Further breakdown from the clinical trial data illustrates just how many patients reached significant weight loss milestones: